EAPI Euroapi S.A.
0.7310EUR-1.08%Mkt Cap: 75.90M $P/E: —Today
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North…
Industry Peers
Drug Manufacturers - Specialty & Generic$64.30BUSDP/E 25.0
$57.06BUSD
$46.10BUSDP/E 65.9
$38.70BUSDP/E 18.3
$28.27BUSDP/E 12.1
$28.80BUSDP/E 11.4
$23.23BUSDP/E 19.4
$20.22BUSD
$14.24BUSDP/E 109.4
$14.55BUSDP/E 21.0
$12.60BUSDP/E 22.8
$11.06BUSD
$10.20BUSDP/E 29.2
$8.50BUSDP/E 18.4
$7.07BUSDP/E 42.3
$7.00BUSDP/E 109.9
$6.77BUSD
$6.53BUSDP/E 23.9
$5.83BUSDP/E 76.6
$4.21BUSDP/E 12.8
| Headline | Source | Time |
|---|---|---|
Older | ||
LLa Montagne | ||
 Euroapi (ENXTPA:EAPI) Stock Sees Fair Value Cut As JPMorgan Rebased Expectations Euroapi is back in focus after analysts cut the official price target from €2.90 to €1.70, with fair value in the reference model shifting from €1.48 to €1.20. Recent commentary, including the latest move from JPMorgan to a €1.70 target, shows how the market is resetting its view of Euroapi to match updated expectations. Read on to see what this may indicate for you and how to track the next steps in the Euroapi story. Analyst Price Targets don't always capture the full story. Head over to... | ||
LL'Usine Nouvelle | ||